Catherine B. Elflein
Corporate Officer/Principal bij BeiGene USA, Inc.
Profiel
Catherine B.
Elflein is currently a Senior Director-Insurance & Risk Management at BeiGene USA, Inc. She previously worked as a Senior Director-Risk Management at Celgene Corp.
and as a Director-Treasury Operations at Celanese Corp.
She also served as an Independent Director at Monmouth Real Estate Investment Corp.
and as a Controller at Captive Insurance Cos Association.
Additionally, she worked as a Principal at Angus Risk Consulting, LLC.
Ms. Elflein holds an undergraduate degree and an MBA from Seton Hall University.
Actieve functies van Catherine B. Elflein
| Bedrijven | Functie | Begin |
|---|---|---|
BeiGene USA, Inc.
 BeiGene USA, Inc. Pharmaceuticals: MajorHealth Technology BeiGene USA, Inc. engages in pharmaceutical development. The company is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-01-2021 |
Eerdere bekende functies van Catherine B. Elflein
| Bedrijven | Functie | Einde |
|---|---|---|
| MONMOUTH REAL ESTATE INVESTMENT CORPORATION | Director/Board Member | 25-02-2022 |
| Angus Risk Consulting, LLC | Corporate Officer/Principal | 01-01-2021 |
| CELGENE | Corporate Officer/Principal | 01-01-2020 |
| Captive Insurance Cos Association | Comptroller/Controller/Auditor | 01-01-2006 |
| CELANESE CORPORATION | Treasurer | 01-01-2004 |
Opleiding van Catherine B. Elflein
| Seton Hall University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CELANESE CORPORATION | Process Industries |
| Bedrijven in privébezit | 5 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Monmouth Real Estate Investment Corp.
 Monmouth Real Estate Investment Corp. Real Estate Investment TrustsFinance Monmouth Real Estate Investment Corp. operates as a real estate investment trust. The firm engages in the ownership and management of real estate. It invests in single tenant, industrial buildings leased to investment-grade tenants on long-term net leases. The company was founded by Eugene W. Landy in 1968 and is headquartered in Holmdel, NJ. | Finance |
| Captive Insurance Cos Association | |
BeiGene USA, Inc.
BeiGene USA, Inc. Pharmaceuticals: MajorHealth Technology BeiGene USA, Inc. engages in pharmaceutical development. The company is headquartered in Cambridge, MA. | Health Technology |
| Angus Risk Consulting, LLC |
